pharmaphorum

NOVEMBER 16, 2020

In his final message as head of the EMA, Rasi said the number of COVID-19 drugs and vaccines being developed by pharma companies is “encouraging,” and pointing to the agency’s pivotal role “in reviewing the available data packages to ensure that our usual high standards of safety, efficacy and quality are achieved and upheld.”.

Vaccines 64

Vaccines Packaging 64

pharmaphorum

SEPTEMBER 18, 2020

In June 2007, AstraZeneca completed the acquisition of vaccine maker MedImmune, buying its drug-development pipeline for $15.2 In April 2008, AstraZeneca also reached an agreement with Ranbaxy, an Indian generic drugmaker, allowing it to produce a generic version of Nexium starting in May 2014.

Vaccines 116

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 116

pharmaphorum

JULY 14, 2021

As we come up on a year and a half of the COVID-19 pandemic, with the global roll out of vaccines slowly gathering pace and big pharma riding high in the opinion charts, the biopharmaceutical sector would do well to learn lessons from the banks. Compliance systems by themselves are not enough. Of course, having rules is necessary.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 105

Pharmaceutical Technology

JULY 23, 2008

The world’s biggest pharmaceutical company Pfizer announced in June 2008 that it would be putting its “full scope and scale” behind a push into the cancer market. “You can get vaccines now to prevent cervical cancer. “And there’s a tremendous opportunity to meet their needs.”

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Compounding Biosimilars 40

Pharmaceutical Technology

SEPTEMBER 10, 2008

Secondly, we conduct pre-clinical research and development in the fields of oncology, cardiovascular disorders, anti-influenza vaccines and diabetology. It will most probably lead to a new anti-flu vaccine. Biotest will be exhibiting at CPhI Worldwide 2008 between 30 September and 2 October, Messe Frankfurt, Germany.

Vaccines 40

Vaccines Biosimilars 40

PharmaShots

APRIL 13, 2023

In 2008, Johnson acquired tissue sealing system developer, SurgRx Pfizer's pharmaceutical segment revenue increased after the acquisitions of Serenex, Encysive Pharmaceuticals, CovX, and Coley Pharmaceuticals Novartis reported a total revenue of $41.4B, under which, its pharmaceutical division faced a revenue loss of $2.6B

Biosimilars 40

Biosimilars Vaccines Pharmaceutical Companies Pharmaceutical Companies 40

Pharmaceutical Technology

AUGUST 26, 2008

We are now one of the ten largest biopharma companies in the world with a rich armoury of new technology, comprising a full suite of technologies, small molecules, antibodies and vaccines to create new human medicines.”

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Development 40

Quality Matters

OCTOBER 13, 2021

In 2007 and 2008, nearly 150 patients died and hundreds more suffered serious adverse reactions after they were treated with heparin, a commonly used blood-thinning drug. Heparin is made from pig intestines, which at that time in China were subject to sharp price increases due to widespread pig deaths from “blue ear disease.”

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Adverse Reactions Prescription Filling Compounding 52

PharmaShots

JANUARY 31, 2023

Founded Year: 2008 No. The Company's premier line of smart safety syringes, Sharps Provensa, prevents accidental needlestick injuries, prevents needle reuse, and minimizes drug and vaccine waste—all while maintaining the intuitive simplicity of conventional syringes. In Sep’22 stakeholders exercised 0.7M of Shares: 2.1M

Vaccines 40

Vaccines Immunization Immunity Diabetes 40

FDA Law Blog: Biosimilars

AUGUST 21, 2023

Things got so bad that Congress acted to shield vaccine manufacturers from liability in order to ensure sufficient availability of vaccines. The same considerations ring true for OTC drugs. FDA, for years, has been concerned with overwarning. billion in damages were brought between 1980 and 1986.

Labelling 40

Labelling Vaccines Communication 40

PharmaShots

MARCH 9, 2023

In addition to serving as Associate Editor-in-Chief of the IEEE Open Access Journal of Circuits and Systems, she has been an Associate Editor of IEEE Transactions on Biomedical Circuits and Systems since 2008. Designation: Global Head Previous company: Merck Global Vaccines (2 yrs. LinkedIn Total experience: 26 yrs.

Clinical Pharmacology 40

Clinical Pharmacology Immunization Immunity Pharmaceutical Companies 40

PharmaShots

APRIL 25, 2023

Founded Year: 2008 Total Employees: ~2110 Headquarters: Dublin, Ireland Market Cap: $1.7M The company strives to discover and develop therapeutic products under its business segments, including General Medicines, Specialty Medicines, and Vaccines. R&D Expenditure: $437.9M R&D Expenditure: $6.6B

HIV Treatment and Prevention Agents 40

HIV Treatment and Prevention Agents Diabetes Packaging Immunity 40

Putting Patients First Blog

SEPTEMBER 9, 2024

Preventive Services The expansion of preventive services, including hepatitis B vaccinations and colorectal cancer screenings, is a positive development for public health. 30 Hepatitis B vaccinations and colorectal cancer screenings are vital components of a comprehensive preventive care strategy. The Gerontologist , 55(2), 309-319.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Documentation Vaccines Communication 40

Safe Biologics

APRIL 25, 2023

Having served in the Department of Health and Human Services’ Office of the Secretary from 2002-2008, including two years as Associate Deputy HHS Secretary, I participated in the development and implementation of Medicare Part D, the program’s prescription drug benefit. In the meantime, I encourage you to read our comments here. [1]

Drug Pricing 130

Drug Pricing Biosimilars Vaccines 130

Safe Biologics

APRIL 25, 2023

Having served in the Department of Health and Human Services’ Office of the Secretary from 2002-2008, including two years as Associate Deputy HHS Secretary, I participated in the development and implementation of Medicare Part D, the program’s prescription drug benefit. In the meantime, I encourage you to read our comments here. [1]

Drug Pricing 130

Drug Pricing Biosimilars Vaccines 130

ALiEM - Pharm Pearls

JUNE 5, 2023

Geneva: World Health Organization; 2008. Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis. 2014;20(2):e130687. doi: 10.3201/eid2002.130687 Anthrax in Humans and Animals. 4th edition. 7, Treatment and prophylaxis. Accessed May 1, 2023.

Vaccines 256

Vaccines 256

Pharmaceutical Technology

MARCH 22, 2023

During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry. While production volumes have now fallen, future vaccine demand is hard to predict, as booster shots could be needed at any point to control emerging variants.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

FEBRUARY 20, 2023

You were the chief operating officer (COO) at Viroclinics-DDL before the acquisition, joining Viroclinics-DDL in 2008. The capabilities of Viroclinics and DDL allowed us to rapidly test repurposed drugs, new vaccines and antiviral solutions for the prevention and treatment of patients affected by COVID-19 in 2020.

Vaccines 52

Vaccines Communication Immunity Immunization 52

Express Pharma

JANUARY 3, 2025

While India was able to leverage the 2008 patent cliff of small molecules, the same playbook will not work for biologics and biosimilars. One of the trends set to define 2025, and the decade ahead, is the 2022-30 patent cliff, and the gradual shift in biopharma revenues from small to large molecules. Omicron BA.5).

Biosimilars 105

Biosimilars Vaccines Diabetes 105

pharmaphorum

JANUARY 21, 2021

Woodcock has most recently been working with the Operation Warp Speed coronavirus vaccine and drug project started by the Trump administration. In a tweet, Woodcock said that she will continue to recuse herself from work relating to the therapeutics developed by Operation Warp Speed, although this does not apply to vaccines.

Medical Schools 105

Medical Schools Vaccines 105

The Thyroid Pharmacist

NOVEMBER 8, 2024

A new test is being developed for MAP detection in support of a vaccine for Crohn’s disease; it has been in clinical trials, and looks very promising. Researchers found they could suppress the autoimmune response if using a vaccine or antibiotic that specifically eradicates E. doi:10.1055/s-2008-1063667. [69] gallinarum. [55]

Immunization 72

Immunization Immunity Diabetes Adverse Reactions 72